TWI238064B
(en)
*
|
1995-06-20 |
2005-08-21 |
Takeda Chemical Industries Ltd |
A pharmaceutical composition for prophylaxis and treatment of diabetes
|
IL118778A
(en)
*
|
1995-07-03 |
1999-07-14 |
Sankyo Co |
Pharmaceutical compositions for the treatment of arteriosclerosis and xanthoma containing an hmg-coa reductase inhibitor
|
EP0851757A2
(de)
|
1995-08-10 |
1998-07-08 |
Warner-Lambert Company |
Methode zur verringerung der exogenen insulinzufuhr bei patienten mit nicht-insulin-abhängigen diabetes mellitus
|
EP0914158B2
(de)
*
|
1996-04-05 |
2006-01-25 |
Takeda Chemical Industries, Ltd. |
Pharmazeutische kombination enthaltend einen wirkstoff mit angiotensin-ii antagonistischer aktivität und einen wirkstoff der die insulin-sensitivität erhöht
|
AU714618B2
(en)
|
1996-07-15 |
2000-01-06 |
Sankyo Company Limited |
Medicinal composition
|
FR2758459B1
(fr)
*
|
1997-01-17 |
1999-05-07 |
Pharma Pass |
Composition pharmaceutique de fenofibrate presentant une biodisponibilite elevee et son procede de preparation
|
US5859037A
(en)
*
|
1997-02-19 |
1999-01-12 |
Warner-Lambert Company |
Sulfonylurea-glitazone combinations for diabetes
|
US6011049A
(en)
*
|
1997-02-19 |
2000-01-04 |
Warner-Lambert Company |
Combinations for diabetes
|
US6291495B1
(en)
*
|
1997-02-24 |
2001-09-18 |
Robert B. Rieveley |
Method and composition for the treatment of diabetes
|
IL133138A0
(en)
*
|
1997-06-18 |
2001-03-19 |
Smithkline Beecham Plc |
Treatment of diabetes with thiazolidinedione and alpha-glucosidase inhibitor
|
EP1787646A3
(de)
*
|
1997-06-18 |
2007-10-03 |
Smithkline Beecham Plc |
Neues Behandlungsverfahren
|
AU783539B2
(en)
*
|
1997-06-18 |
2005-11-10 |
Smithkline Beecham Plc |
Treatment of diabetes with thiazolidinedione and sulphonylurea
|
AU778947B2
(en)
*
|
1997-06-18 |
2004-12-23 |
Smithkline Beecham Plc |
Treatment of diabetes with thiazolidinedione and metformin
|
US20020028768A1
(en)
*
|
1997-06-18 |
2002-03-07 |
Smithkline Beecham P.L.C. |
Treatment of diabetes with rosiglitazone and insulin
|
PL337510A1
(en)
*
|
1997-06-18 |
2000-08-28 |
Smithkline Beecham Plc |
Treatment of diabetes by means of derivatives of thiazolydinone and sulphonylurea
|
US20010049380A1
(en)
*
|
1997-06-18 |
2001-12-06 |
Smith Stephen Alistair |
Treatment of diabetes with thiazolidinedione and sulphonylurea
|
US20020004515A1
(en)
*
|
1997-06-18 |
2002-01-10 |
Smith Stephen Alistair |
Treatment of diabetes with thiazolidinedione and metformin
|
GB9715298D0
(en)
*
|
1997-07-18 |
1997-09-24 |
Smithkline Beecham Plc |
Novel method of treatment
|
AU782419B2
(en)
*
|
1997-07-18 |
2005-07-28 |
Smithkline Beecham Plc |
Treatment of diabetes with thiazolidinedione, insulin secretagogue and diguanide
|
GB9715306D0
(en)
*
|
1997-07-18 |
1997-09-24 |
Smithkline Beecham Plc |
Novel method of treatment
|
US20020016287A1
(en)
*
|
1997-07-18 |
2002-02-07 |
Smithkline Beecham P.L.C. |
Treatment of diabetes with thiazolidinedione, insulin secretagogue and diguanide
|
GB9715295D0
(en)
*
|
1997-07-18 |
1997-09-24 |
Smithkline Beecham Plc |
Novel method of treatment
|
WO1999020277A1
(fr)
*
|
1997-10-20 |
1999-04-29 |
Dainippon Pharmaceutical Co., Ltd. |
Composition medicamenteuse a dissolution rapide
|
US6583157B2
(en)
|
1998-01-29 |
2003-06-24 |
Tularik Inc. |
Quinolinyl and benzothiazolyl modulators
|
AU759255B2
(en)
|
1998-01-29 |
2003-04-10 |
Amgen, Inc. |
PPAR-gamma modulators
|
US6099859A
(en)
|
1998-03-20 |
2000-08-08 |
Andrx Pharmaceuticals, Inc. |
Controlled release oral tablet having a unitary core
|
US7105552B2
(en)
*
|
1998-05-08 |
2006-09-12 |
Theracos, Inc. |
Heterocyclic analogs of diphenylethylene compounds
|
US6221897B1
(en)
*
|
1998-06-10 |
2001-04-24 |
Aventis Pharma Deutschland Gmbh |
Benzothiepine 1,1-dioxide derivatives, a process for their preparation, pharmaceuticals comprising these compounds, and their use
|
CN1305376A
(zh)
|
1998-06-30 |
2001-07-25 |
武田药品工业株式会社 |
治疗糖尿病的药物组合物
|
JP2000080047A
(ja)
*
|
1998-06-30 |
2000-03-21 |
Takeda Chem Ind Ltd |
医 薬
|
EP0974356B1
(de)
*
|
1998-07-15 |
2003-09-24 |
Merck Sante |
Tabletten enthaltend eine Kombination von Glibenclamid und Metformin
|
US6376549B1
(en)
*
|
1998-09-17 |
2002-04-23 |
Akesis Pharmaceuticals, Inc. |
Metforimin-containing compositions for the treatment of diabetes
|
AU1330800A
(en)
|
1998-10-29 |
2000-05-22 |
Board Of Regents, The University Of Texas System |
Use of thiazolidinediones derivatives for preventing uterine contractions in premature labour or lactation
|
AP1692A
(en)
*
|
1998-11-12 |
2006-12-12 |
Smithkline Beecham Plc |
Pharmaceutical composition for modified release of an insulin sensitiser and another antidiabetic agent.
|
JP2002529504A
(ja)
*
|
1998-11-12 |
2002-09-10 |
スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー |
インスリン感作物質および他の抗糖尿病薬の放出修飾のための医薬組成物
|
US20030153607A1
(en)
*
|
1998-11-12 |
2003-08-14 |
Smithkline Beecham P.L.C. |
Novel composition and use
|
DZ2937A1
(fr)
*
|
1998-11-12 |
2004-03-15 |
Smithkline Beecham Plc |
Compositions nouvelles de sensibilidants à l'insuline.
|
US20040081697A1
(en)
*
|
1998-11-12 |
2004-04-29 |
Smithkline Beecham P.L.C. |
Pharmaceutical composition for modified release of an insulin sensitiser and another antidiabetic agent
|
US20040102486A1
(en)
*
|
1998-11-12 |
2004-05-27 |
Smithkline Beecham Corporation |
Novel method of treatment
|
US6958324B2
(en)
|
1998-12-02 |
2005-10-25 |
Inotek Pharmaceuticals Corporation |
Inosine compounds and their use for treating or preventing an inflamation or a reperfusion disease
|
US20080269265A1
(en)
*
|
1998-12-22 |
2008-10-30 |
Scott Miller |
Inhibition Of Raf Kinase Using Symmetrical And Unsymmetrical Substituted Diphenyl Ureas
|
DK1143955T3
(da)
*
|
1998-12-24 |
2005-11-14 |
Metabasis Therapeutics Inc |
En kombination af FBPase-inhibitorer og insulinsensibiliseringsmidler til behandling af diabetes
|
US6756360B1
(en)
|
1998-12-24 |
2004-06-29 |
Metabasis Therapeutics, Inc. |
Combination of FBPase inhibitors and insulin sensitizers for the treatment of diabetes
|
CA2361303C
(en)
*
|
1999-01-29 |
2007-11-20 |
Takeda Chemical Industries, Ltd. |
Punch for preparing tablets
|
JP4799720B2
(ja)
*
|
1999-01-29 |
2011-10-26 |
武田薬品工業株式会社 |
コーティング処理を施した打錠用杵
|
GB0001662D0
(en)
|
1999-02-06 |
2000-03-15 |
Zeneca Ltd |
Pharmaceutical compositions
|
WO2000059855A1
(en)
*
|
1999-04-01 |
2000-10-12 |
Esperion Therapeutics, Inc. |
Ether compounds, compositions, and uses thereof
|
US7407978B2
(en)
*
|
1999-04-06 |
2008-08-05 |
Theracos, Inc. |
Heterocyclic analogs of diphenylethylene compounds
|
JP2000355550A
(ja)
*
|
1999-04-14 |
2000-12-26 |
Takeda Chem Ind Ltd |
ケトーシス改善剤
|
TWI249401B
(en)
*
|
1999-04-14 |
2006-02-21 |
Takeda Chemical Industries Ltd |
Agent for improving ketosis
|
US6815457B1
(en)
*
|
1999-04-23 |
2004-11-09 |
Smithkline Beecham P.L.C. |
Thiazolidinedione derivative and its use as antidiabetic
|
GB9910693D0
(en)
*
|
1999-05-07 |
1999-07-07 |
Univ Liverpool |
A compound for use in medicine
|
US6214842B1
(en)
*
|
1999-05-12 |
2001-04-10 |
Michael S. Malamas |
Amino-thiazolidinediones useful in the treatment of insulin resistance and hyperglycemia
|
DE60032898T2
(de)
*
|
1999-06-18 |
2007-10-25 |
Merck & Co., Inc. |
Arylthiazolidindion- und aryloxazolidinderivate
|
PT1133312E
(pt)
*
|
1999-06-21 |
2007-11-30 |
Lilly Co Eli |
Uso sinergístico de tiazolidinodionas com péptido 1 semelhante ao glucagon e os seus agonistas para tratar diabetes não insulino-dependente
|
WO2001000223A2
(en)
*
|
1999-06-25 |
2001-01-04 |
Minimed Inc. |
Multiple agent diabetes therapy
|
US7041691B1
(en)
|
1999-06-30 |
2006-05-09 |
Amgen Inc. |
Compounds for the modulation of PPARγ activity
|
NZ516455A
(en)
*
|
1999-06-30 |
2004-03-26 |
Tularik Inc |
Compounds for the modulation of PPARgamma activity
|
AU779730B2
(en)
*
|
1999-06-30 |
2005-02-10 |
Amgen, Inc. |
Compounds for the modulation of PPARgamma activity
|
AU2005200818B2
(en)
*
|
1999-09-17 |
2008-07-17 |
Novartis Ag |
Method of treating metabolic disorders, especially diabetes, or a disease or condition associated with diabetes
|
US6878749B2
(en)
|
1999-09-17 |
2005-04-12 |
Novartis Ag |
Method of treating metabolic disorders, especially diabetes, or a disease or condition associated with diabetes
|
AR028299A1
(es)
*
|
1999-09-17 |
2003-05-07 |
Novartis Ag |
Una composicion farmaceutica que comprende nateglinida, un proceso para su preparacion y el uso de dicha composicion para la preparacion de un medicamento para el tratamiento de desordenes metabolicos, especialmente diabetes, o de una enfermedad o condicion asociada con diabetes.
|
US6559188B1
(en)
|
1999-09-17 |
2003-05-06 |
Novartis Ag |
Method of treating metabolic disorders especially diabetes, or a disease or condition associated with diabetes
|
US6414002B1
(en)
|
1999-09-22 |
2002-07-02 |
Bristol-Myers Squibb Company |
Substituted acid derivatives useful as antidiabetic and antiobesity agents and method
|
JP4719393B2
(ja)
*
|
1999-10-06 |
2011-07-06 |
敏男 宮田 |
カルボニルストレス改善剤
|
EP1218015A2
(de)
*
|
1999-10-08 |
2002-07-03 |
Novartis AG |
Zusammensetzung welche nateglinide and eine andere antidiabetische verbindung enthält
|
US6274622B1
(en)
*
|
1999-10-27 |
2001-08-14 |
Frederick H. Hausheer |
Method of treating diabetic ophthalmopathy
|
WO2001032157A2
(en)
|
1999-11-03 |
2001-05-10 |
Bristol-Myers Squibb Company |
Pharmaceutical composition comprising a combination of metformin and glibenclamide
|
US6586438B2
(en)
|
1999-11-03 |
2003-07-01 |
Bristol-Myers Squibb Co. |
Antidiabetic formulation and method
|
MY125516A
(en)
*
|
1999-11-16 |
2006-08-30 |
Smithkline Beecham Plc |
Novel composition based on thiazolidinedione and metformin and use
|
US6660021B1
(en)
|
1999-12-23 |
2003-12-09 |
Advanced Cardiovascular Systems, Inc. |
Intravascular device and system
|
US6575997B1
(en)
|
1999-12-23 |
2003-06-10 |
Endovascular Technologies, Inc. |
Embolic basket
|
US6402771B1
(en)
|
1999-12-23 |
2002-06-11 |
Guidant Endovascular Solutions |
Snare
|
WO2001047509A2
(en)
*
|
1999-12-24 |
2001-07-05 |
Smithkline Beecham P.L.C. |
Composition for the treatment diabetes mellitus containing an insuline sensitizer and agent used in the treatment of cardiac conditions
|
GB9930688D0
(en)
*
|
1999-12-24 |
2000-02-16 |
Smithkline Beecham Plc |
Novel method of treatment
|
US6695813B1
(en)
|
1999-12-30 |
2004-02-24 |
Advanced Cardiovascular Systems, Inc. |
Embolic protection devices
|
US7918820B2
(en)
|
1999-12-30 |
2011-04-05 |
Advanced Cardiovascular Systems, Inc. |
Device for, and method of, blocking emboli in vessels such as blood arteries
|
US20010036479A1
(en)
|
2000-01-14 |
2001-11-01 |
Gillian Cave |
Glyburide composition
|
AU2001229601A1
(en)
*
|
2000-01-24 |
2001-07-31 |
Inotek Corporation |
Method and composition for modulating an immune response
|
US6540982B1
(en)
*
|
2000-01-25 |
2003-04-01 |
Aeropharm Technology Incorporated |
Medical aerosol formulation
|
WO2001058491A1
(fr)
*
|
2000-02-10 |
2001-08-16 |
Takeda Chemical Industries, Ltd. |
Medicament comprenant une combinaison
|
CA2401356A1
(en)
*
|
2000-02-24 |
2001-08-30 |
Takeda Chemical Industries, Ltd. |
Combination drug
|
US6524621B2
(en)
|
2000-05-01 |
2003-02-25 |
Aeropharm Technology Inc. |
Core formulation
|
US6451342B2
(en)
|
2000-05-01 |
2002-09-17 |
Aeropharm Technology Incorporated |
Core formulation comprised of troglitazone and a biguanide
|
US6548049B1
(en)
*
|
2000-05-01 |
2003-04-15 |
Aeropharm Technology Incorporated |
Medicinal aerosol formulation
|
US6610272B1
(en)
*
|
2000-05-01 |
2003-08-26 |
Aeropharm Technology Incorporated |
Medicinal aerosol formulation
|
US6296874B1
(en)
*
|
2000-05-01 |
2001-10-02 |
Aeropharm Technology Incorporated |
Core formulation comprising troglitazone and abiguanide
|
US6461639B2
(en)
|
2000-05-01 |
2002-10-08 |
Aeropharm Technology, Inc. |
Core formulation
|
WO2001082916A2
(en)
|
2000-05-03 |
2001-11-08 |
Tularik Inc. |
Combination therapeutic compositions and methods of use
|
US6270797B1
(en)
*
|
2000-05-18 |
2001-08-07 |
Usv Limited |
Sustained release pharmaceutical composition containing glipizide and method for producing same
|
US6939362B2
(en)
*
|
2001-11-27 |
2005-09-06 |
Advanced Cardiovascular Systems, Inc. |
Offset proximal cage for embolic filtering devices
|
US20030171399A1
(en)
|
2000-06-28 |
2003-09-11 |
Tularik Inc. |
Quinolinyl and benzothiazolyl modulators
|
US7563774B2
(en)
|
2000-06-29 |
2009-07-21 |
Metabasis Therapeutics, Inc. |
Combination of FBPase inhibitors and antidiabetic agents useful for the treatment of diabetes
|
US6964670B1
(en)
|
2000-07-13 |
2005-11-15 |
Advanced Cardiovascular Systems, Inc. |
Embolic protection guide wire
|
US20060089389A1
(en)
*
|
2000-08-22 |
2006-04-27 |
Malcolm Allison |
Combination
|
PE20020617A1
(es)
*
|
2000-08-22 |
2002-08-05 |
Novartis Ag |
Composicion que comprende un antagonista del receptor at1 y un potenciador de la secrecion de insulina o un sensibilizante a la insulina
|
US20080241070A1
(en)
*
|
2000-09-21 |
2008-10-02 |
Elan Pharma International Ltd. |
Fenofibrate dosage forms
|
US20030224058A1
(en)
*
|
2002-05-24 |
2003-12-04 |
Elan Pharma International, Ltd. |
Nanoparticulate fibrate formulations
|
US7276249B2
(en)
*
|
2002-05-24 |
2007-10-02 |
Elan Pharma International, Ltd. |
Nanoparticulate fibrate formulations
|
US20040087597A1
(en)
*
|
2000-10-12 |
2004-05-06 |
Masaki Kitahara |
Preventives and remedies for complications of diabetes
|
US6506203B1
(en)
|
2000-12-19 |
2003-01-14 |
Advanced Cardiovascular Systems, Inc. |
Low profile sheathless embolic protection system
|
BRPI0206432A2
(pt)
|
2001-01-12 |
2016-10-25 |
Sun Pharmaceutical Ind Ltd |
métodos para administrar dois ou mais agentes terapêuticos ativos e para tratar diabetes melito ou sintomas associados com diabetes melito em um humano e sistema de liberação espaçada de medicamento
|
US6852694B2
(en)
|
2001-02-21 |
2005-02-08 |
Medtronic Minimed, Inc. |
Stabilized insulin formulations
|
DE60204611T2
(de)
|
2001-02-28 |
2006-05-11 |
Pfizer Products Inc., Groton |
Sulfonyl-pyridazinon-derivate zur Verwendung als Aldose-reduktase-inhibitoren
|
US20040110693A1
(en)
*
|
2001-03-02 |
2004-06-10 |
Friedrich Trepel |
Agent for treating diabetes mellitus
|
KR200249057Y1
(ko)
*
|
2001-03-22 |
2001-10-19 |
김진환 |
뚜껑, 받침대에 합체된 하수역류. 악취방지 장치
|
PL365294A1
(en)
*
|
2001-03-30 |
2004-12-27 |
Pfizer Products Inc. |
Pyridazinone aldose reductase inhibitors
|
JPWO2002080924A1
(ja)
*
|
2001-04-03 |
2004-07-29 |
山之内製薬株式会社 |
アリールエテンスルホンアミド誘導体の新規な用途
|
WO2002080887A2
(en)
*
|
2001-04-10 |
2002-10-17 |
Sun Pharmaceutical Industries Limited |
Timed pulse release composition
|
SE0101982D0
(sv)
*
|
2001-06-01 |
2001-06-01 |
Astrazeneca Ab |
Pharmaceutical combination
|
JP2002360666A
(ja)
*
|
2001-06-11 |
2002-12-17 |
Takeda Chem Ind Ltd |
コバルト合金を用いた打錠用杵臼
|
US6737401B2
(en)
*
|
2001-06-28 |
2004-05-18 |
Metronic Minimed, Inc. |
Methods of evaluating protein formulation stability and surfactant-stabilized insulin formulations derived therefrom
|
US6599307B1
(en)
|
2001-06-29 |
2003-07-29 |
Advanced Cardiovascular Systems, Inc. |
Filter device for embolic protection systems
|
US7338510B2
(en)
|
2001-06-29 |
2008-03-04 |
Advanced Cardiovascular Systems, Inc. |
Variable thickness embolic filtering devices and method of manufacturing the same
|
JP2004536843A
(ja)
*
|
2001-07-10 |
2004-12-09 |
エアロファーム テクノロジー インコーポレイテッド |
ピオグリタゾンおよびビグアナイドを含むコア製剤
|
MXPA04000176A
(es)
*
|
2001-07-10 |
2004-10-27 |
Kos Life Sciences Inc |
Formulacion de nucleo.
|
US6638294B1
(en)
|
2001-08-30 |
2003-10-28 |
Advanced Cardiovascular Systems, Inc. |
Self furling umbrella frame for carotid filter
|
US6592606B2
(en)
|
2001-08-31 |
2003-07-15 |
Advanced Cardiovascular Systems, Inc. |
Hinged short cage for an embolic protection device
|
US8262689B2
(en)
|
2001-09-28 |
2012-09-11 |
Advanced Cardiovascular Systems, Inc. |
Embolic filtering devices
|
AU2002349705A1
(en)
|
2001-12-03 |
2003-06-17 |
Japan Tobacco Inc. |
Azole compound and medicinal use thereof
|
US7241304B2
(en)
|
2001-12-21 |
2007-07-10 |
Advanced Cardiovascular Systems, Inc. |
Flexible and conformable embolic filtering devices
|
DE10200138A1
(de)
*
|
2002-01-04 |
2003-07-17 |
Karl Winkler |
Kombination von einem PPAR-Agonisten mit PPAR-alpha Aktivität mit einem Induktor des LDL-Rezeptors
|
TWI327462B
(en)
*
|
2002-01-18 |
2010-07-21 |
Sumitomo Chemical Co |
Condensed heterocyclic sulfonyl urea compound, a herbicide containing the same, and a method for weed control using the same
|
US6682759B2
(en)
|
2002-02-01 |
2004-01-27 |
Depomed, Inc. |
Manufacture of oral dosage forms delivering both immediate-release and sustained-release drugs
|
US20030187074A1
(en)
*
|
2002-03-04 |
2003-10-02 |
Javed Hussain |
Oral compositions for treatment of diabetes
|
TW200305415A
(en)
*
|
2002-03-22 |
2003-11-01 |
Novartis Ag |
Combination of organic compounds
|
US20050142065A1
(en)
*
|
2002-04-26 |
2005-06-30 |
Koki Kato |
Screening method
|
US20070264348A1
(en)
*
|
2002-05-24 |
2007-11-15 |
Elan Pharma International, Ltd. |
Nanoparticulate fibrate formulations
|
US8911781B2
(en)
|
2002-06-17 |
2014-12-16 |
Inventia Healthcare Private Limited |
Process of manufacture of novel drug delivery system: multilayer tablet composition of thiazolidinedione and biguanides
|
US7214387B2
(en)
|
2002-08-02 |
2007-05-08 |
Penwest Pharmaceuticals Company |
Sustained release formulations of metformin
|
US7232828B2
(en)
*
|
2002-08-10 |
2007-06-19 |
Bethesda Pharmaceuticals, Inc. |
PPAR Ligands that do not cause fluid retention, edema or congestive heart failure
|
KR20050053677A
(ko)
|
2002-09-20 |
2005-06-08 |
안드렉스 랩스 엘엘씨 |
비구아나이드와 티아졸리디네디온 유도체를 함유한 약제학적 투여형태
|
US8084058B2
(en)
|
2002-09-20 |
2011-12-27 |
Watson Pharmaceuticals, Inc. |
Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
|
US9060941B2
(en)
*
|
2002-09-20 |
2015-06-23 |
Actavis, Inc. |
Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
|
US7959946B2
(en)
*
|
2002-09-20 |
2011-06-14 |
Watson Pharmaceuticals, Inc. |
Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
|
US7785627B2
(en)
*
|
2002-09-20 |
2010-08-31 |
Watson Pharmaceuticals, Inc. |
Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
|
US7331973B2
(en)
|
2002-09-30 |
2008-02-19 |
Avdanced Cardiovascular Systems, Inc. |
Guide wire with embolic filtering attachment
|
US7252675B2
(en)
|
2002-09-30 |
2007-08-07 |
Advanced Cardiovascular, Inc. |
Embolic filtering devices
|
UA80991C2
(en)
*
|
2002-10-07 |
2007-11-26 |
|
Solid preparation containing an insulin resistance improving drug and an active ingredient useful as a remedy for diabetes
|
US20040088000A1
(en)
|
2002-10-31 |
2004-05-06 |
Muller Paul F. |
Single-wire expandable cages for embolic filtering devices
|
DE10252666A1
(de)
*
|
2002-11-11 |
2004-08-05 |
Grünenthal GmbH |
N-Piperidyl-cyclohexan-Derivate
|
IN192749B
(de)
*
|
2002-11-15 |
2004-05-15 |
Ranbaxy Lab Ltd |
|
DE10261067A1
(de)
*
|
2002-12-24 |
2004-08-05 |
Nutrinova Nutrition Specialties & Food Ingredients Gmbh |
Cholesterinsenkendes Mittel, enthaltend eine n-3-Fettsäure
|
AU2004205642C1
(en)
|
2003-01-14 |
2012-01-12 |
Arena Pharmaceuticals, Inc. |
1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia
|
US6794401B2
(en)
*
|
2003-01-17 |
2004-09-21 |
Bexel Pharmaceuticals, Inc. |
Amino acid phenoxy ethers
|
DE10302452B4
(de)
*
|
2003-01-23 |
2005-02-24 |
Aventis Pharma Deutschland Gmbh |
Carbonylamino-substituierte Acyl-phenyl-harnstoffderivate, Verfahren zu deren Herstellung und deren Verwendung
|
US7179941B2
(en)
|
2003-01-23 |
2007-02-20 |
Sanofi-Aventis Deutschland Gmbh |
Carbonylamino-substituted acyl phenyl urea derivatives, process for their preparation and their use
|
KR101114808B1
(ko)
*
|
2003-01-29 |
2012-02-15 |
다케다 야쿠힌 고교 가부시키가이샤 |
피복 제제의 제조법
|
US7572910B2
(en)
*
|
2003-02-20 |
2009-08-11 |
Pfizer, Inc. |
Pyridazinone aldose reductase inhibitors
|
US8591540B2
(en)
|
2003-02-27 |
2013-11-26 |
Abbott Cardiovascular Systems Inc. |
Embolic filtering devices
|
US20060210633A1
(en)
*
|
2003-04-03 |
2006-09-21 |
Sun Pharmaceutical Industries Limited |
Programmed drug delivery system
|
BRPI0409136A
(pt)
*
|
2003-04-09 |
2006-04-25 |
Japan Tobacco Inc |
composto heteroaromático pentacìclico e uso medicinal do mesmo
|
US7820158B2
(en)
*
|
2003-04-10 |
2010-10-26 |
Surmodics, Inc. |
Ligand-coupled initiator polymers and methods of use
|
US9345671B2
(en)
*
|
2003-04-28 |
2016-05-24 |
Daiichi Sankyo Company, Limited |
Adiponectin production enhancer
|
US7772272B2
(en)
*
|
2003-04-28 |
2010-08-10 |
Daiichi Sankyo Company, Limited |
Method for enhancing glucose uptake into warm-blooded animal adipocytes
|
JP2007502847A
(ja)
*
|
2003-05-13 |
2007-02-15 |
シントン・ベスローテン・フェンノートシャップ |
チアゾリジンジオン誘導体およびその化合物を製造する方法
|
US7230016B2
(en)
*
|
2003-05-13 |
2007-06-12 |
Synthon Ip Inc. |
Pioglitazone salts, such as pioglitazone sulfate, and pharmaceutical compositions and processes using the same
|
US20050004179A1
(en)
*
|
2003-05-22 |
2005-01-06 |
Pedersen Ward A. |
Methods and materials for treating, detecting, and reducing the risk of developing Alzheimer's Disease
|
WO2005000299A1
(en)
*
|
2003-06-27 |
2005-01-06 |
Dr. Reddy's Research Foundation |
Compositions comprising balaglitazone and further antidiabetic compounds
|
US20050013863A1
(en)
*
|
2003-07-18 |
2005-01-20 |
Depomed, Inc., A Corporation Of The State Of California |
Dual drug dosage forms with improved separation of drugs
|
JP2007508241A
(ja)
*
|
2003-07-31 |
2007-04-05 |
バイエル・フアーマシユーチカルズ・コーポレーシヨン |
Pde10a阻害剤を用いる糖尿病および関連障害の処置方法
|
EP1510208A1
(de)
*
|
2003-08-22 |
2005-03-02 |
Fournier Laboratories Ireland Limited |
Metformin-Statin-Kombination enthaltende pharmazeutische Zusammensetzungen
|
US20050054731A1
(en)
*
|
2003-09-08 |
2005-03-10 |
Franco Folli |
Multi-system therapy for diabetes, the metabolic syndrome and obesity
|
US7223761B2
(en)
|
2003-10-03 |
2007-05-29 |
Amgen Inc. |
Salts and polymorphs of a potent antidiabetic compound
|
MXPA06004698A
(es)
*
|
2003-10-27 |
2006-07-05 |
Innodia Inc |
Metodos y composiciones para utilizarse en el tratamiento de la diabetes.
|
KR100952090B1
(ko)
*
|
2003-10-31 |
2010-04-13 |
다케다 야쿠힌 고교 가부시키가이샤 |
인슐린 감작제, 인슐린 분비촉진제 및 폴리옥시에틸렌소르비탄 지방산 에스테르를 함유하는 고체 제제
|
US7892251B1
(en)
|
2003-11-12 |
2011-02-22 |
Advanced Cardiovascular Systems, Inc. |
Component for delivering and locking a medical device to a guide wire
|
US20050163842A1
(en)
*
|
2003-12-31 |
2005-07-28 |
Garth Boehm |
Rosiglitazone and metformin formulations
|
WO2005065654A2
(en)
*
|
2003-12-31 |
2005-07-21 |
Alpharma, Inc. |
Rosiglitazone formulations
|
US7360069B2
(en)
*
|
2004-01-13 |
2008-04-15 |
Hewlett-Packard Development Company, L.P. |
Systems and methods for executing across at least one memory barrier employing speculative fills
|
JP2005200419A
(ja)
*
|
2004-01-16 |
2005-07-28 |
National Health Research Inst |
癌治療法
|
US20070197602A1
(en)
*
|
2004-02-09 |
2007-08-23 |
Hashime Kanazawa |
Combined pharmaceutical composition
|
WO2005080387A2
(en)
*
|
2004-02-20 |
2005-09-01 |
Synthon B.V. |
Processes for making pioglitazone and compounds of the processes
|
WO2005084666A1
(en)
*
|
2004-03-02 |
2005-09-15 |
Abeille Pharmaceuticals, Inc. |
Co-formulations of kits of bioactive agents
|
US7678129B1
(en)
|
2004-03-19 |
2010-03-16 |
Advanced Cardiovascular Systems, Inc. |
Locking component for an embolic filter assembly
|
US7161756B2
(en)
*
|
2004-05-10 |
2007-01-09 |
Tandberg Data Storage Asa |
Method and system for communication between a tape drive and an external device
|
CN1327840C
(zh)
*
|
2004-06-08 |
2007-07-25 |
天津药物研究院 |
一种药物组合物及其在制备用于治疗糖尿病中的应用
|
EP2248531A1
(de)
*
|
2004-08-03 |
2010-11-10 |
Emisphere Technologies, Inc. |
Antidiabetische orale Insulinbiguanidkombination
|
CN101432004A
(zh)
*
|
2004-09-14 |
2009-05-13 |
伊利舍医药品公司 |
用于控制的碳水化合物消化的联合治疗
|
MXPA04009236A
(es)
*
|
2004-09-23 |
2006-03-27 |
Jorge Luis Rosado Loria |
Composicion sinergistica para el tratamiento de diabetes y sus comorbilidades.
|
JP2008019169A
(ja)
*
|
2004-10-25 |
2008-01-31 |
Osaka Univ |
新規ppar調節剤およびそのスクリーニング方法
|
US20060089387A1
(en)
*
|
2004-10-26 |
2006-04-27 |
Le Huang |
Stabilized pharmaceutical composition comprising antidiabetic agent
|
US7833513B2
(en)
|
2004-12-03 |
2010-11-16 |
Rhode Island Hospital |
Treatment of Alzheimer's Disease
|
US9259305B2
(en)
|
2005-03-31 |
2016-02-16 |
Abbott Cardiovascular Systems Inc. |
Guide wire locking mechanism for rapid exchange and other catheter systems
|
US20100028439A1
(en)
*
|
2005-05-23 |
2010-02-04 |
Elan Pharma International Limited |
Nanoparticulate stabilized anti-hypertensive compositions
|
GT200600218A
(es)
*
|
2005-06-10 |
2007-03-28 |
|
Formulación y proceso de compresión directa
|
JP2009500401A
(ja)
*
|
2005-07-07 |
2009-01-08 |
ポステック ファンデーション |
糖吸収調節剤及び薬学的組成物
|
US20070015839A1
(en)
*
|
2005-07-14 |
2007-01-18 |
Franco Folli |
Daily Dosage Regimen for Treating Diabetes, Obesity, Metabolic Syndrome and Polycystic Ovary Syndrome
|
AU2006271230A1
(en)
*
|
2005-07-22 |
2007-01-25 |
Warner Chilcott Company, Llc |
Compositions for reducing the incidence of drug induced arrhythmia
|
MXPA05013220A
(es)
*
|
2005-12-06 |
2007-06-05 |
Leopoldo De Jesus Espinosa Abdala |
Composiciones farmaceuticas que comprenden sustancias antidiabeticas combinadas para su uso en diabetes mellitus tipo 2.
|
WO2007072992A2
(en)
|
2005-12-22 |
2007-06-28 |
Takeda Pharmaceutical Company Limited |
Solid preparation containing an insulin sensitizer
|
FR2896157B1
(fr)
|
2006-01-13 |
2008-09-12 |
Merck Sante Soc Par Actions Si |
Combinaison de derives de triazine et d'agents de stimulation de secretion d'insuline.
|
WO2007105730A1
(ja)
*
|
2006-03-13 |
2007-09-20 |
Kyowa Hakko Kogyo Co., Ltd. |
インスリン抵抗性改善剤
|
UA96441C2
(ru)
|
2006-03-16 |
2011-11-10 |
Метаболик Солюшнз Девелопмент Компани |
Фармацевтическая композиция, которая содержит аналог тиазолидиндиона митоглитазон, для лечения заболеваний, опосредованных метаболическим воспалением
|
EP2001461A4
(de)
*
|
2006-03-31 |
2010-06-09 |
Wellstat Therapeutics Corp |
Kombinationsbehandlung für stoffwechselerkrankungen
|
ATE523474T1
(de)
*
|
2006-04-11 |
2011-09-15 |
Sorbwater Technology As |
Verfahren zur entfernung von materialien aus einem flüssigkeitsstrom
|
US7435741B2
(en)
*
|
2006-05-09 |
2008-10-14 |
Teva Pharmaceutical Industries, Ltd. |
2-N{5-[[4-[2-(methyl-2-pyridinylamino) ethoxy] phenyl]methyl]-2,4-thiazolidinedione} butanedioic acid, methods of preparation and compositions with rosiglitazone maleate
|
EP2037928B1
(de)
|
2006-06-26 |
2012-01-11 |
Amgen Inc. |
Verfahren zur behandlung von atherosklerose
|
US7752724B2
(en)
*
|
2006-06-27 |
2010-07-13 |
Lumino, Inc. |
Method of cutting blinds
|
WO2008026668A1
(fr)
*
|
2006-08-31 |
2008-03-06 |
Daiichi Sankyo Company, Limited |
Composition médicale contenant un agent d'amélioration de la résistance à l'insuline
|
US20080182880A1
(en)
*
|
2006-09-28 |
2008-07-31 |
Mailatur Sivaraman Mohan |
Pioglitazone composition
|
US8217025B2
(en)
*
|
2006-11-17 |
2012-07-10 |
Harbor Therapeutics, Inc. |
Drug screening and treatment methods
|
EP2016076A2
(de)
*
|
2007-01-22 |
2009-01-21 |
Teva Pharmaceutical Industries Ltd. |
Polymorphe formen von rosiglitazon-hydrobromid und herstellungsverfahren dafür
|
PT2106260T
(pt)
|
2007-01-25 |
2018-03-05 |
Naia Metabolic Inc |
Sensibilizadores de insulina e métodos de tratamento
|
DK2107905T3
(da)
*
|
2007-02-01 |
2011-01-31 |
Takeda Pharmaceutical |
Fast sammensætning omfattende alogliptin og pioglitazon
|
US20080249156A1
(en)
*
|
2007-04-09 |
2008-10-09 |
Palepu Nageswara R |
Combinations of statins and anti-obesity agent and glitazones
|
BRPI0810525B8
(pt)
|
2007-04-11 |
2021-05-25 |
Omeros Corp |
uso de pioglitazona ou rosiglitazona pra tratar a dependência em álcool, cocaína e nicotina, composições farmacêuticas e formas de dosagem, e combinações farmacêuticas contendo pioglitazona ou rosiglitazona
|
US11241420B2
(en)
|
2007-04-11 |
2022-02-08 |
Omeros Corporation |
Compositions and methods for prophylaxis and treatment of addictions
|
US20160331729A9
(en)
*
|
2007-04-11 |
2016-11-17 |
Omeros Corporation |
Compositions and methods for prophylaxis and treatment of addictions
|
US8216209B2
(en)
|
2007-05-31 |
2012-07-10 |
Abbott Cardiovascular Systems Inc. |
Method and apparatus for delivering an agent to a kidney
|
CN103601792B
(zh)
|
2007-06-04 |
2016-06-29 |
协同医药品公司 |
有效用于胃肠功能紊乱、炎症、癌症和其他疾病治疗的鸟苷酸环化酶激动剂
|
US8969514B2
(en)
|
2007-06-04 |
2015-03-03 |
Synergy Pharmaceuticals, Inc. |
Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
|
US7867273B2
(en)
|
2007-06-27 |
2011-01-11 |
Abbott Laboratories |
Endoprostheses for peripheral arteries and other body vessels
|
EP2489730B1
(de)
|
2007-07-26 |
2015-12-30 |
Amgen, Inc |
Modifizierte Lecithin-Cholesterin-Acyltransferase-Enzyme
|
AU2008301905B2
(en)
*
|
2007-09-14 |
2013-06-27 |
Cirius Therapeutics, Inc. |
Thiazolidinedione analogues for the treatment of hypertension
|
WO2009038107A1
(ja)
*
|
2007-09-21 |
2009-03-26 |
Kissei Pharmaceutical Co., Ltd. |
2型糖尿病治療用の組合せ医薬
|
US20100311092A1
(en)
*
|
2007-11-30 |
2010-12-09 |
Kurland Irwin J |
Metabolic fuel switching biomarker
|
US8551524B2
(en)
|
2008-03-14 |
2013-10-08 |
Iycus, Llc |
Anti-diabetic combinations
|
EP2190417A2
(de)
*
|
2008-03-26 |
2010-06-02 |
Teva Pharmaceutical Industries Ltd. |
Pharmazeutische zusammensetzung mit insulinsensibilisator und insulinsekretagogum
|
CA2726917C
(en)
|
2008-06-04 |
2018-06-26 |
Synergy Pharmaceuticals Inc. |
Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
|
EP3241839B1
(de)
|
2008-07-16 |
2019-09-04 |
Bausch Health Ireland Limited |
Zur behandlung von erkrankungen des magen-darm-trakts, entzündlichen erkrankungen, krebs und anderen erkrankungen geeignete agonisten von guanylatcyclase
|
US8846315B2
(en)
|
2008-08-12 |
2014-09-30 |
Zinfandel Pharmaceuticals, Inc. |
Disease risk factors and methods of use
|
EP2789695B1
(de)
|
2008-08-12 |
2019-10-30 |
Zinfandel Pharmaceuticals, Inc. |
Anti-Alzheimer-Behandlung von Probanden, die durch Nachweis einer genetischen Variante im TOMM40-Gen bei rs 10524523 identifiziert wurden
|
TW201031664A
(en)
|
2009-01-26 |
2010-09-01 |
Targacept Inc |
Preparation and therapeutic applications of (2S,3R)-N-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)-3,5-difluorobenzamide
|
CN102348457A
(zh)
|
2009-03-11 |
2012-02-08 |
奥默罗斯公司 |
预防和治疗成瘾的组合物和方法
|
US20110038848A1
(en)
|
2009-08-12 |
2011-02-17 |
Melaleuca, Inc. |
Dietary supplement compositions for cardiovascular health
|
JP5697260B2
(ja)
|
2009-11-13 |
2015-04-08 |
東レ株式会社 |
糖尿病の治療または予防薬
|
ES2629170T3
(es)
*
|
2009-12-04 |
2017-08-07 |
Senhwa Biosciences, Inc. |
Pirazolopirimidinas y heterociclos relacionados como inhibidores de CK2
|
RU2564661C2
(ru)
*
|
2009-12-15 |
2015-10-10 |
МЕТАБОЛИК СОЛЮШНЗ ДЕВЕЛОПМЕНТ КОМПАНИ, ЭлЭлСи |
Соли тиазолидиндиона со сниженным сродством к ppar для лечения нарушений обмена веществ
|
US20130053350A1
(en)
*
|
2009-12-15 |
2013-02-28 |
Metabolic Solutions Development Company, Llc |
Ppar-sparing thiazolidinediones and combinations for the treatment of neurodegenerative diseases
|
JP2013523681A
(ja)
|
2010-03-30 |
2013-06-17 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
Sglt2インヒビター及びppar−ガンマアゴニストを含む医薬組成物並びにその使用
|
MX2012011631A
(es)
*
|
2010-04-06 |
2013-01-18 |
Arena Pharm Inc |
Moduladores del receptor gpr119 y el tratamiento de trastornos relacionados con el mismo.
|
RU2526153C2
(ru)
*
|
2010-07-15 |
2014-08-20 |
Олег Ильич Эпштейн |
Способ повышения фармакологической активности действующего вещества лекарственного средства и фармацевтическая композиция
|
WO2012028934A1
(en)
|
2010-09-01 |
2012-03-08 |
Lupin Limited |
Pharmaceutical composition comprising metformin and pioglitazone
|
US9616097B2
(en)
|
2010-09-15 |
2017-04-11 |
Synergy Pharmaceuticals, Inc. |
Formulations of guanylate cyclase C agonists and methods of use
|
EA201390421A1
(ru)
|
2010-09-22 |
2013-09-30 |
Арена Фармасьютикалз, Инк. |
Модуляторы рецептора gpr119 и лечение связанных с ним нарушений
|
US9102666B2
(en)
|
2011-01-10 |
2015-08-11 |
Zinfandel Pharmaceuticals, Inc. |
Methods and drug products for treating Alzheimer's disease
|
HUE026715T2
(en)
*
|
2011-01-20 |
2016-07-28 |
Bionevia Pharmaceuticals Inc |
Modified release pharmaceutical composition comprising Epalrestat or a derivative thereof and methods of their use
|
WO2013034174A1
(en)
|
2011-09-06 |
2013-03-14 |
ZENTIVA Saglik Ürünleri Sanayi ve Ticaret A.S. |
Solid preparations of pioglitazone and glimepiride
|
KR102051030B1
(ko)
|
2011-10-28 |
2019-12-02 |
루메나 파마수티컬즈, 인코포레이티드 |
소아 담즙울체성 간 질환 치료용 담즙산 재순환 억제제
|
EP2788384B1
(de)
|
2011-12-08 |
2017-08-09 |
Amgen Inc. |
Agonistische menschliche lcat-antigenbindende proteine und ihre verwendung in der therapie
|
US20130158077A1
(en)
|
2011-12-19 |
2013-06-20 |
Ares Trading S.A. |
Pharmaceutical compositions
|
US9504679B2
(en)
|
2011-12-19 |
2016-11-29 |
Bjoern Colin Kahrs |
Pharmaceutical compositions comprising glitazones and Nrf2 activators
|
WO2014151200A2
(en)
|
2013-03-15 |
2014-09-25 |
Synergy Pharmaceuticals Inc. |
Compositions useful for the treatment of gastrointestinal disorders
|
AU2014235215A1
(en)
|
2013-03-15 |
2015-10-01 |
Synergy Pharmaceuticals Inc. |
Agonists of guanylate cyclase and their uses
|
CN105764916B
(zh)
|
2013-06-05 |
2021-05-18 |
博士医疗爱尔兰有限公司 |
鸟苷酸环化酶c的超纯激动剂、制备和使用所述激动剂的方法
|
CA2926685A1
(en)
|
2013-10-09 |
2015-04-16 |
Synergy Pharmaceuticals, Inc. |
Agonists of guanylate cyclase useful for downregulation of pro-inflammatory cytokines
|
RU2572706C1
(ru)
*
|
2014-06-30 |
2016-01-20 |
Олег Ильич Эпштейн |
Способ повышения фармакологической активности действующего вещества лекарственного средства и фармацевтическая композиция
|
EA036404B1
(ru)
|
2015-02-06 |
2020-11-06 |
Интерсепт Фармасьютикалз, Инк. |
Фармацевтические композиции для комбинированной терапии
|
ES2929526T3
(es)
|
2015-06-22 |
2022-11-29 |
Arena Pharm Inc |
Sal cristalina de L-arginina del ácido (R)-2-(7-(4-ciclopentil-3-(trifluorometil)benciloxi)-1,2,3,4-tetrahidrociclo-penta[b]indol-3-il)acético para su uso en trastornos asociados al receptor S1P1
|
EP3568134A1
(de)
|
2017-01-16 |
2019-11-20 |
Institut National de la Sante et de la Recherche Medicale (INSERM) |
Verfahren und pharmazeutische zusammensetzungen zur reduzierung der cd95-vermittelten zellmotilität
|
WO2019241576A1
(en)
|
2018-06-14 |
2019-12-19 |
Astrazeneca Uk Limited |
Methods for lowering blood sugar with a metformin pharmaceutical composition
|
AU2020284135A1
(en)
|
2019-05-30 |
2022-01-06 |
Intercept Pharmaceuticals, Inc. |
Pharmaceutical compositions comprising a FXR agonist and a fibrate for use in the treatment of cholestatic liver disease
|
CN112869173A
(zh)
*
|
2021-01-18 |
2021-06-01 |
广州富诺营养科技有限公司 |
一种复合维生素矿物质制剂及其制备方法
|